The American diabetes association (ADA) agrees that SGLT2 inhibitors should be avoided in cases of severe illness, in people with ketonemia or ketonuria, and during prolonged fasting and surgical procedures. The gene discussed is SLC5A2; the disease is diabetes mellitus.